Psychiatry and Neurology, Neurology · Middletown, NY
NPI
1265429922
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
155 Crystal Run Rd
Middletown, NY, 10941
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$512K
19,015 services
Medicare patients, 2024
921
Average age 74
Drug cost, 2024
$2.4M
4,540 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Jaeger was code 99214 (office e&m - established), 988 times for 566 patients. In total David A Jaeger billed 19,015 services in 77 codes, and Medicare paid $512K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 988 | 566 | $98.09 | $97K |
| 99213 Office E&M - Established | Office | 319 | 270 | $68.88 | $22K |
| 36415 Venipuncture Blood Collection | Office | 173 | 146 | $8.65 | $1,496 |
| 99204 Office E&M - New | Office | 158 | 158 | $127.04 | $20K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 90 | 18 | $4.03 | $363 |
| 80053 Clinical Chemistry | Office | 82 | 76 | $10.35 | $849 |
| 85025 Blood Count | Office | 70 | 66 | $7.61 | $533 |
| 99215 Office E&M - Established | Office | 60 | 59 | $139.95 | $8,397 |
| 86618 Immunoassay | Office | 58 | 52 | $16.69 | $968 |
| 96415 Chemotherapy Administration | Office | 51 | 17 | $23.52 | $1,199 |
| 82746 Clinical Chemistry | Office | 49 | 48 | $14.41 | $706 |
| 82607 Clinical Chemistry | Office | 44 | 43 | $14.78 | $650 |
| 96365 Intravenous Infusion, Hydration | Office | 43 | 36 | $50.26 | $2,161 |
| 96375 Injection Administration | Office | 42 | 21 | $13.02 | $547 |
| 99205 Office E&M - New | Office | 33 | 33 | $169.22 | $5,584 |
By year: 2022 $596K for 14,919 services; 2023 $506K for 17,551 services; 2024 $512K for 19,015 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 173 | 146 | $8.65 | $1,496 |
| 80053 Clinical Chemistry | 82 | 76 | $10.35 | $849 |
| 85025 Blood Count | 70 | 66 | $7.61 | $533 |
| 86618 Immunoassay | 58 | 52 | $16.69 | $968 |
| 82746 Clinical Chemistry | 49 | 48 | $14.41 | $706 |
| 82607 Clinical Chemistry | 44 | 43 | $14.78 | $650 |
| 84443 Clinical Chemistry | 32 | 32 | $16.46 | $527 |
| 85652 Clinical Chemistry | 30 | 29 | $2.65 | $79.5 |
| 86140 Clinical Chemistry | 28 | 27 | $5.08 | $142 |
| 82550 Clinical Chemistry | 13 | 13 | $6.38 | $82.94 |
Medicare prescription drug claims, 2024
In 2024, the drug David A Jaeger prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,090 prescriptions and refills. In total David A Jaeger wrote 4,540 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,090 | 2,401 | 273 | $41K |
| Memantine Hcl Er Memantine Hcl | 347 | 667 | 72 | $38K |
| Baclofen Generic | 243 | 369 | 54 | $9,124 |
| Gabapentin Generic | 232 | 444 | 71 | $3,986 |
| Donepezil Hcl Generic | 171 | 397 | 53 | $1,665 |
| Rytary Carbidopa/Levodopa | 162 | 275 | 33 | $319K |
| Clonazepam Generic | 142 | 162 | 33 | $1,543 |
| Levetiracetam Generic | 120 | 190 | 26 | $4,949 |
| Primidone Generic | 115 | 201 | 20 | $3,469 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 113 | 290 | 34 | $4,253 |
| Pregabalin Generic | 101 | 139 | 27 | $3,372 |
| Neupro Rotigotine | 95 | 127 | 23 | $102K |
| Amantadine Amantadine Hcl | 93 | 203 | 28 | $6,232 |
| Rivastigmine Generic | 92 | 138 | 20 | $15K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 87 | 172 | 24 | $1,630 |
Brand drugs: - claims; generic drugs: 4,001 claims; opioid claims: 24.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David A Jaeger were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.